Related Experiment Video
Updated: Apr 8, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Healthcare Utilization and Costs After Appropriate or Inappropriate Implantable Defibrillator Shocks: A Retrospective
Takashi Noda1, Tomoko Matsumoto2, Yuji Tanaka2
1Cardiovascular Center, Kindai University Hospital, Sakai, Osaka, Japan.
Insights
Implantable cardioverter-defibrillator (ICD) and CRT-D shocks in Japan lead to significant healthcare utilization and costs, especially for appropriate shocks requiring hospitalization. Further research is needed to optimize patient management and resource use.
Area of Science:
- Cardiology
- Health Economics
- Medical Device Technology
Background:
- Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy with defibrillators (CRT-Ds) are crucial for preventing sudden cardiac death.
- Limited data exists on healthcare utilization and costs following ICD/CRT-D shock events specifically within Japan.
Purpose of the Study:
- To analyze real-world data on healthcare utilization and costs associated with ICD/CRT-D shock events in Japan.
- To provide insights into the economic impact of these events in the Japanese healthcare system.
Main Methods:
- Retrospective analysis of real-world data from four tertiary hospitals in Japan (January 2022 - June 2024).
- Inclusion of adult patients with ICD/CRT-D implants, focusing on those experiencing shock events.
- Examination of hospitalization rates, duration of stay, and associated healthcare costs.
Main Results:
- Out of 1,807 patients, 84 experienced 146 ICD/CRT-D shock events (4.6%); 33 patients had multiple episodes.
- Appropriate shocks (83.6%) were linked to significantly longer hospital stays and higher costs compared to inappropriate shocks (16.4%).
- Hospitalization was required in 37.7% of shock cases.
Conclusions:
- ICD/CRT-D shock events in Japan incur substantial healthcare utilization and costs, particularly appropriate shocks.
- Findings underscore the need for optimized management strategies to improve patient care and resource allocation in Japan.
- This study highlights the importance of real-world data in understanding the economic burden of cardiac device therapies.
Background:
Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy with defibrillators (CRT-Ds) effectively prevent sudden cardiac death. However, there is a lack of detailed data on healthcare utilization and healthcare cost following ICD/CRT-D shock events in Japan. This study aimed to examine real-world data (RWD) stored in an emergency department system to clarify healthcare utilization and healthcare costs associated with ICD/CRT-D shocks in Japan.
Methods And Results:
This retrospective study analyzed RWD from four tertiary hospitals between January 2022 to June 2024. Among 1,807 ICD/CRT-D implanted adult patients, 84 patients (4.6%) who visited the hospital at least once following an ICD/CRT-D shock event were identified. Of these, a total of 146 ICD/CRT-D shock events were observed, with 33 patients (39.3%) experiencing multiple episodes. Of these, 122 (83.6%) were appropriate and 24 (16.4%) were inappropriate. Hospitalization was required in 55 (37.7%) cases. Appropriate shocks were associated with longer hospital stays (24.6 ± 29.3 vs. 12.5 ± 4.2 days) and higher costs (1,123,531 ± 2,195,483 JPY vs. 67,091 ± 131,282 JPY) than inappropriate shocks.
Conclusion:
In this multicenter retrospective study using real-world data in Japan, we investigated the healthcare utilization and costs associated with ICD/CRT-D shock events. Our findings provide valuable insight into post-shock care in daily practice and highlight the need for optimized management strategies to improve care delivery and resource use in the Japanese clinical setting.
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

